证券记录 · 已归档季度
OPK
OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research
15被追踪持有人
-2Δ持有人
100.01M持有股份
$155.02M报告持仓市值
+0新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -11.8% ·
股份流向 -0.7% ·
净新建仓位 -20.0%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 325.17K | $509,427 | n/a | n/a |
| Q2 2026 | 82 | -5 | 114.38M | $171.40M | +3 | −9 |
| Q1 2026 | 91 | +2 | 116.06M | $132.34M | +8 | −6 |
| Q4 2025 | 88 | 0 | 132.71M | $167.24M | +1 | −1 |
| Q3 2025 | 15 | -2 | 100.01M | $155.02M | n/a | −3 |
| Q2 2025 | 15 | 0 | 96.47M | $127.34M | +2 | −2 |
| Q1 2025 | 12 | +1 | 38.88M | $64.54M | +2 | −1 |
| Q4 2024 | 11 | -1 | 30.02M | $44.13M | n/a | −1 |
| Q3 2024 | 11 | +1 | 16.46M | $24.53M | +1 | n/a |
| Q2 2024 | 10 | n/a | 13.40M | $16.75M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 37.54M | -1.8% | $58.18M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 33.17M | +5.5% | $51.42M | 0.0% | ▲ Add | 2 | SEC ↗ ×13 |
| 3 | Geode Capital Management ✦ (被动) | 10.99M | +5.5% | $17.04M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 9.00M | +4.8% | $13.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 2.87M | +207.0% | $4.45M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 6 | Goldman Sachs Group ✦ | 2.39M | n/a | $3.70M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | Two Sigma Investments ✦ | 1.26M | -31.6% | $1.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 1.05M | n/a | $1.63M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 9 | Morgan Stanley ✦ | 837.60K | n/a | $1.30M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 10 | T. Rowe Price ✦ | 343.29K | -21.5% | $533,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 279.88K | +28.7% | $433,806 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 175.00K | 0.0% | $271,250 | 0.0% | Held | 6 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 59.70K | +56.7% | $92,535 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 30.00K | -1.0% | $46,500 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 16.56K | +2.8% | $25,674 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $4.42M | 曾为 0.0% |
| Millennium Management | $918,430 | 曾为 0.0% |
| Norges Bank | $52,110 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 231 持有人, 200.30M 股份, $226.79M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据